TRAITEMENT D'ETATS INFLAMMATOIRES PAR ADMINISTRATION D'UNE PROTEINE DE FUSION ANTAGONISTE DU RECEPTEUR D'INTERLEUKINE-1

• 收藏
• 分享

专利权人:

INC.;REGENERON PHARMACEUTICALS

发明人:

TESSARI, EBEN,PAOLINI, JOHN

申请号：

CA3075538

公开号：

CA3075538A1

申请日:

2018.09.26

申请国别(地区):

CA

年份:

2019

代理人:

摘要：

The present invention provides, among other things, methods of treating post- cardiac injury syndrome (PCIS) or pericarditis, comprising a step of administering to a subject in need of treatment an interleukin-1 receptor-Fc fusion protein at a therapeutically effective dose and an administration interval for a treatment period sufficient to improve, stabilize or reduce one or more signs and symptoms of pericarditis relative to a control.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/